期刊文献+

204例胰腺癌患者生存分析 被引量:8

Survival analysis of 204 patients with pancreatic cancer
原文传递
导出
摘要 目的观察胰腺癌患者临床特征、血常规、生化指标对预后的影响。方法电话随访病理诊断明确为胰腺癌患者的生存期,收集临床特征、血常规、生化指标,分析资料齐全的204例患者各因素对预后的影响。结果204例胰腺癌患者1、2、3年生存率分别为32.8%、13.7%、2.9%,中位生存期为6.4个月。单因素分析显示未手术治疗患者较行根治性切除术或姑息手术患者的生存期短(P〈0.01);肿瘤标志物高、血红蛋白低、白细胞高、血清白蛋白低、血清肌酐水平高的患者生存期短(P〈0.01);丙氨酸转氨酶及天冬氨酸转氨酶高的患者较正常患者生存期长(P〈0.05)。COX回归分析显示分期晚的患者生存时间短(P〈0.01);血清白蛋白低、血清肌酐高患者生存时间短(P〈0.05)。结论手术、临床分期、肿瘤标志物水平、血红蛋白、白细胞、血清白蛋白、血清肌酐均为影响胰腺癌患者预后的独立危险因素。 Objective To investigate the impacts of clinical features, blood and biochemical parameters on survival of patients with pancreatic cancer. Methods Two hundred and four patients with pathologically performed pancreatic cancer were retrospectively analyzed. All patients were followed-up by means of phone. Results The survival rate of 204 patients with pancreatic cancer was 32.8% at 1-year, 13.7% at 3-year and 2.9% at 5-year, with medium survival time of 6.4 months. Univariate examination showed that the long survival time was found in patients with radical or palliate operation in comparison with those without (P〈0.01). The factors that impacted on the survival times were high tumor marker, .high serum creatinine, high white blood cells, low hemoglobin and low albumin (P〈0.01). Whereas the patients with high levels of ALT and AST had long survival time (P〈0.05). COX regression analysis revealed that those with advanced stage, low albumin and high creatinine had short survival time(P〈0.05). Conclusions Surgery, tumor stage, tumor marker, hemoglobin, white blood cell, albumin and creatinine are independent prognostic factors.
出处 《中华消化杂志》 CAS CSCD 北大核心 2010年第4期236-240,共5页 Chinese Journal of Digestion
关键词 胰腺癌 无病生存 回顾性研究 Pancreatic neoplasms Disease-free survival Retrospective studies
  • 相关文献

参考文献9

  • 1Jemal A,Siegel R,Ward E,et al.Cancer statistics,2007.CA Cancer J Clin,2007,57.-43-66. 被引量:1
  • 2Thomson BN,Banting SW0 Gibbs P.Pancreatic cancercurrent management.Aust Faro Physician,2006,35:212-217. 被引量:1
  • 3张群华.我国胰腺外科实验研究的发展方向[J].中华实验外科杂志,2003,20(7):583-584. 被引量:6
  • 4Park JK,Yoon YB,Kim YT,et al.Survival and prognostic factors of unresectable pancreatic cancer.J Clin Gastroenterol,2008,42:86-91. 被引量:1
  • 5Boeck S,Stieber P,Holdenrieder S,et al.Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer.Oncology,2006,70:255-264. 被引量:1
  • 6Louhimo J,Alfthan H,Stenman UH,et al.Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA,CA 19-9 and CA 242 in pancreatic cancer.Oncology,2004,66:126-131. 被引量:1
  • 7Tanaka T,Ikeda M,Okusaka T,et al.Prognostic factors in japanese patients with advanced pancreatic cancer treated with single-agent gemcitabine as first-line therapy.Jpn J Clin Oncol,2008,38:755-761. 被引量:1
  • 8Tas F,Aykan F,Alici S,et al.Prognostic factors in pancreatic carcinoma:serum LDH levels predict survival in metastatic disease.Am J Clin Oncol,2001,24:547-550. 被引量:1
  • 9Pizzi S,Porzionato A,Pasquali C,et al.Glucose transporter1 expression and prognostic significance in pancreatic carcinogenesis.Histol Histopathol,2009,24:175-185. 被引量:1

共引文献5

同被引文献35

引证文献8

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部